Previous 10 | Next 10 |
Company Expects Beginning of First in Human Trial Activation in Second Quarter of 2023 Deltacel is Being Developed to Treat Solid Malignancies, Which Comprise 90% of All Cancers Kiromic BioPharma, Inc. (NASDAQ: KRBP) (“Kiromic” or the “Company”), ...
2023-04-17 10:02:16 ET Gainers: Prometheus Biosciences ( RXDX ) +69% . CNS Pharmaceuticals ( CNSP ) +53% . Revelation Biosciences ( REVB ) +29% . Windtree Therapeutics ( WINT ) +26% . Kiromic BioPharma ( KRBP ) +22% . Loser...
2023-04-17 08:21:00 ET CNS Pharmaceuticals ( CNSP ) +72% . Presto Automation ( PRST ) +55% . Prometheus Biosciences ( RXDX ) +70% soars 70%, Merck dips after ~$11B buyout deal. Dragonfly Energy ( DFLI ) +49% . Kiromic BioPharma ( ...
2023-04-06 10:02:19 ET Gainers: Bullfrog AI ( BFRG ) +16% . HUTCHMED (China) ( HCM ) +10% . Aprea Therapeutics ( APRE ) +8% . Clearside Biomedical ( CLSD ) +5% . Soleno Therapeutics ( SLNO ) +5% . Losers: Scilex ( SCLX ...
2023-04-04 12:51:54 ET Gainers: Cardlytics ( CDLX ) +62% . Assure Holdings ( IONM ) +56% . The NFT Gaming Company ( NFTG ) +42% . Bullfrog AI Holdings ( BFRG ) +32% . Bellerophon Therapeutics ( BLPH ) +27% . Austin Gold ( A...
2023-04-03 13:44:04 ET Kiromic BioPharma ( NASDAQ: KRBP ) stock rose ~5% on Monday after company said it submitted an investigational new drug (IND) application to the U.S. Food and Drug Administration (FDA) to start a phase 1 of KB-GDT-01 (Deltacel), in combination with an an...
Deltacel is Being Developed as an Allogeneic, Non-Viral, Non-Engineered Off-the-Shelf Gamma Delta T-Cell Therapy Kiromic BioPharma, Inc. (NASDAQ: KRBP) (“Kiromic” or the “Company”), a clinical-stage fully-integrated biotherapeutics company using its propr...
2023-03-10 16:48:25 ET Kiromic BioPharma ( NASDAQ: KRBP ) has announced that it will effect a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-30 effective on March 10, 2023. Kiromic common stock will begin trading on a split-adjusted ...
Kiromic BioPharma, Inc. (NASDAQ: KRBP) (“Kiromic” or the “Company”), a clinical-stage fully-integrated biotherapeutics company using its proprietary DIAMOND® artificial intelligence and data mining platform to develop cell therapies with a focus on immune-oncolo...
2023-03-09 14:31:53 ET Penny stocks are shares of small companies with a price of less than $5 per share. These stocks are known for their high volatility and low liquidity, making them a risky investment option. However, they also offer some unique benefits and opportunities for traders an...
News, Short Squeeze, Breakout and More Instantly...
Kiromic BioPharma Inc. Company Name:
KRBP Stock Symbol:
NASDAQ Market:
Kiromic BioPharma Inc. Website:
Enrollment in the Expansion Phase Expected to Commence in September Deltacel Safety Confirmed at Day 30 in Trial’s Fifth Patient; Efficacy Results on this Patient Expected in August Kiromic BioPharma, Inc. (OTCQB: KRBP) (“Kiromic” or the “Company...
Follow-up Findings Show Stable Disease FDA and IRB Approve IND for a Single-Use, Single-Patient Treatment with Deltacel Fast Track Designation Request Submitted to FDA Complete Enrollment in Trial’s Second Cohort Expected in July Kiromic BioPharma, Inc. ...
Favorable Follow-up Findings Include Stable Disease and a 13% Decrease in Tumor Size Kiromic BioPharma, Inc. (OTCQB: KRBP) (“Kiromic” or the “Company”) reports favorable six-month follow-up results from the first patient enrolled in the Deltacel-01 Phase ...